We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aqua Bty Di | LSE:ABTU | London | Ordinary Share | COM SHS USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 662.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMABTU
RNS Number : 5305E
Aqua Bounty Technologies, Inc.
09 May 2017
AquaBounty Technologies, Inc.
Results for the quarter ended March 31, 2017
MAYNARD, Massachusetts, May 9, 2017 - AquaBounty Technologies, Inc. (NASDAQ: AQB; AIM: ABTU) ("AquaBounty" or the "Company"), a biotechnology company focused on enhancing productivity in the aquaculture market and a majority-owned subsidiary of Intrexon Corporation (NYSE: XON), announces the Company's financial results for the quarter ended March 31, 2017.
Financial and Operational Summary:
-- Completed a US$25.0 million equity subscription with Intrexon Corporation
-- Implemented a 1-for-30 reverse share split and completed the listing of the Company's common shares on the NASDAQ Capital Market
-- Continued to progress the Company's renovation plans at Rollo Bay and submitted a follow-on request to authorities to construct a broodstock facility and a grow-out facility on the site
-- Seeking shareholder approval to de-list the Company's common shares from trading on AIM
Ronald Stotish, Chief Executive Officer of AquaBounty, stated: "We are pleased by the progress we've made during the first quarter on our 2017 goals. We completed the listing of our common shares on the NASDAQ Capital Market, aided by the infusion of $25.0 million in new equity from Intrexon. This has allowed us to continue with, and expand upon, our plans to renovate the former Atlantic Sea Smolt plant in Rollo Bay on Prince Edward Island. We have submitted an application to the provincial regulatory authorities for the construction of a broodstock facility to house our non-transgenic Atlantic salmon stock and a 250 metric ton recirculating aquaculture system ("RAS") facility to grow out our AquAdvantage(R) Salmon. We see this as the first step in our commercialization plan. We are also continuing to search for sites to establish our first RAS grow-out facility in the United States, and we expect to complete this process this year."
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements regarding the nature of and progress toward the Company's commercialization plan; the anticipated progress to be made by the Company during 2017; the completion of the Rollo Bay renovations and the regulatory approval for, and construction of, a broodstock facility and grow-out unit; and the establishment of a grow-out facility in the United States. Forward-looking statements may be identified with words such as "will," "may," "expect," "plan," "anticipate," "upcoming," "believe," "estimate", or similar terminology, and the negative of these terms. Forward-looking statements are not promises or guarantees of future performance, and are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Forward-looking statements speak only as of the date hereof, and, except as required by law, we undertake no obligation to update or revise these forward-looking statements. For additional information regarding these and other risks faced by us, refer to our public filings with the Securities and Exchange Commission ("SEC"), available on the Investors section of our website at www.aquabounty.com and on the SEC's website at www.sec.gov.
Enquiries:
Generally
AquaBounty Technologies, Inc.
David A. Frank, Chief Financial Officer +1 978 648 6000
AIM Investors
Stifel Nicolaus Europe Limited
Stewart Wallace +44 20 7710 7600
Luther Pendragon
Harry Chathli, Claire Norbury +44 20 7618 9100
AquaBounty Technologies, Inc.
Consolidated Balance Sheets
(Unaudited)
As of March December 31, 31, 2017 2016 ------------------------------------------------- --------------- ---------------- Assets Current assets: Cash and cash equivalents $ 25,472,604 $ 3,324,609 Certificate of deposit 10,749 10,666 Other receivables 92,455 164,743 Inventory 101,046 - Prepaid expenses and other current assets 264,228 72,983 -------------------------------------------------- -------------- ------------- Total current assets 25,941,082 3,573,001 Property, plant and equipment, net 2,199,311 1,723,707 Definite-lived intangible assets, net 195,273 198,698 Indefinite-lived intangible assets 191,800 191,800 Other assets 21,628 21,628 -------------------------------------------------- ------------- Total assets $ 28,549,094 $ 5,708,834 ================================================== ========== ========= Liabilities and stockholders' equity Current liabilities: Accounts payable and accrued liabilities $ 784,662 $ 1,017,851 Current debt 18,249 17,913 -------------------------------------------------- -------------- ------------- Total current liabilities 802,911 1,035,764 Long-term debt 2,786,839 2,645,015 -------------------------------------------------- -------------- ------------- Total liabilities 3,589,750 3,680,779 Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value, 200,000,000 shares authorized; 8,885,009 (2016: 6,463,936) shares outstanding 8,885 6,464 Additional paid-in capital 126,580,621 101,581,724 Accumulated other comprehensive loss (300,558) (286,272) Accumulated deficit (101,329,604) (99,273,861) -------------------------------------------------- Total stockholders' equity 24,959,344 2,028,055 -------------------------------------------------- -------------- ------------- Total liabilities and stockholders' equity $ 28,549,094 $ 5,708,834 ================================================== ========== =========
AquaBounty Technologies, Inc.
Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
Three Months Ended March 31, 2017 2016 ------------------------------------------ ------------ -------------- Costs and expenses Sales and marketing $ 208,288 $ 201,377 Research and development 720,022 815,257 General and administrative 1,120,788 779,525 Total costs and expenses 2,049,098 1,796,159 ------------------------------------------- ----------- ----------- Operating loss (2,049,098) (1,796,159) Other income (expense) Gain on disposal of equipment - 2,861 Interest expense (5,280) (24,306) Other income (expense), net (1,365) (1,373) ------------------------------------------- ----------- ----------- Total other income (expense) (6,645) (22,818) ------------------------------------------- ----------- ----------- Net loss $(2,055,743) $(1,818,977) =========================================== ========== ========== Other comprehensive loss: Foreign currency translation loss (14,286) (96,993) Total other comprehensive loss (14,286) (96,993) ------------------------------------------- ----------- ----------- Comprehensive loss $(2,070,029) $(1,915,970) =========================================== ========== ========== Basic and diluted net loss per share $ (0.24) $ (0.35) Weighted average number of common shares - basic and diluted 8,400,795 5,248,306
This information is provided by RNS
The company news service from the London Stock Exchange
END
QRFLFFSIERITIID
(END) Dow Jones Newswires
May 09, 2017 02:00 ET (06:00 GMT)
1 Year Aqua Bty Di Chart |
1 Month Aqua Bty Di Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions